United States Pharmaceuticals

BridgeBio Pharma Inc (BBIO)

Track

Over the last 90 days, BridgeBio Pharma Inc. has seen significant insider selling, with a total sell value of over $44 million. Notably, CEO Neil Kumar and President & CFO Thomas Trimarchi have engaged in multiple planned and proposed sales, totaling hundreds of thousands of dollars each. No insider purchases were recorded during this period.
Stock chart
Ticker: BBIO Exchange: NSM
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
Kumar Neil
Chief Executive Officer
6 sales — total 600,000 USD
Planned sale 5 Jun 2026
Value US$3,901,937.73 | Price 12.71 | Shares 93,843
Planned sale 5 Jun 2026
Value US$4,558,846.12 | Price 401.01 | Shares 98,521
Planned sale 5 Jun 2026
Value US$100,000.00 | Price 67.20 | Shares 1,000
Planned sale 5 Jun 2026
Value US$100,000.00 | Price 68.96 | Shares 1,000
Planned sale 5 Jun 2026
Value US$100,000.00 | Price 67.88 | Shares 1,000
Planned sale 5 Jun 2026
Value US$100,000.00 | Price 67.20 | Shares 1,000
Planned sale 4 Jun 2026
Value US$3,035,971.28 | Price 188.65 | Shares 87,725
Planned sale 4 Jun 2026
Value US$1,935,277.07 | Price 381.25 | Shares 97,115
Planned sale 4 Jun 2026
Value US$100,000.00 | Price 66.72 | Shares 1,000
Planned sale 4 Jun 2026
Value US$100,000.00 | Price 65.72 | Shares 1,000
Planned sale 4 Jun 2026
Value US$100,000.00 | Price 68.27 | Shares 1,000
Planned sale 4 Jun 2026
Value US$100,000.00 | Price 67.74 | Shares 1,000
Planned sale 4 Jun 2026
Value US$100,000.00 | Price 66.72 | Shares 1,000
Planned sale 4 Jun 2026
Value US$100,000.00 | Price 65.72 | Shares 1,000
Planned sale 21 May 2026
Value US$100,000.00 | Price 70.92 | Shares 1,000
Planned sale 21 May 2026
Value US$100,000.00 | Price 70.48 | Shares 1,000
Planned sale 21 May 2026
Value US$100,000.00 | Price 69.22 | Shares 1,000
Planned sale 21 May 2026
Value US$100,000.00 | Price 68.30 | Shares 1,000
Planned sale 21 May 2026
Value US$100,000.00 | Price 67.57 | Shares 1,000
Proposed sale 21 May 2026
Value US$100,000.00 | Price 68.22 | Shares 1,000
Proposed sale 21 May 2026
Value US$100,000.00 | Price 68.22 | Shares 1,000
Planned sale 18 May 2026
Value US$210,712.49 | Price 65.95 | Shares 3,195
Planned sale 18 May 2026
Value US$677,706.69 | Price 64.82 | Shares 10,456
Proposed sale 18 May 2026
Value US$888,419.37 | Price 65.08 | Shares 13,651
Planned sale 15 May 2026
Value US$13,824.00 | Price 69.12 | Shares 200
Planned sale 15 May 2026
Value US$103,164.21 | Price 68.23 | Shares 1,512
Planned sale 15 May 2026
Value US$141,003.06 | Price 67.53 | Shares 2,088
Planned sale 15 May 2026
Value US$413,464.36 | Price 66.69 | Shares 6,200
Planned sale 8 May 2026
Value US$64,930.32 | Price 68.35 | Shares 950
Planned sale 8 May 2026
Value US$341,845.76 | Price 67.35 | Shares 5,076
Planned sale 8 May 2026
Value US$931,374.09 | Price 66.65 | Shares 13,974
Planned sale 8 May 2026
Value US$64,930.32 | Price 68.35 | Shares 950
Planned sale 8 May 2026
Value US$341,913.10 | Price 67.35 | Shares 5,077
Planned sale 8 May 2026
Value US$931,307.44 | Price 66.65 | Shares 13,973
Planned sale 7 May 2026
Value US$31,021.90 | Price 69.09 | Shares 449
Planned sale 7 May 2026
Value US$569,858.08 | Price 68.38 | Shares 8,334
Planned sale 7 May 2026
Value US$757,090.29 | Price 67.49 | Shares 11,217
Planned sale 7 May 2026
Value US$31,091.00 | Price 69.09 | Shares 450
Planned sale 7 May 2026
Value US$569,789.71 | Price 68.38 | Shares 8,333
Planned sale 7 May 2026
Value US$757,091.42 | Price 67.50 | Shares 11,217
Planned sale 30 Apr 2026
Value US$143,160.00 | Price 71.58 | Shares 2,000
Planned sale 10 Apr 2026
Value US$1,492,076.00 | Price 74.60 | Shares 20,000
Planned sale 10 Apr 2026
Value US$1,492,096.00 | Price 74.60 | Shares 20,000
Planned sale 9 Apr 2026
Value US$589,123.86 | Price 75.53 | Shares 7,800
Planned sale 9 Apr 2026
Value US$382,379.06 | Price 74.57 | Shares 5,128
Planned sale 9 Apr 2026
Value US$520,801.17 | Price 73.64 | Shares 7,072
Planned sale 9 Apr 2026
Value US$566,661.00 | Price 75.55 | Shares 7,500
Planned sale 9 Apr 2026
Value US$395,403.32 | Price 74.60 | Shares 5,300
Planned sale 9 Apr 2026
Value US$530,239.68 | Price 73.64 | Shares 7,200
Proposed sale 9 Apr 2026
Value US$8,896,800.00 | Price 74.14 | Shares 120,000
Planned sale 13 Mar 2026
Value US$675,567.75 | Price 69.23 | Shares 9,759
Planned sale 13 Mar 2026
Value US$700,345.12 | Price 68.39 | Shares 10,241
Planned sale 13 Mar 2026
Value US$713,448.91 | Price 69.20 | Shares 10,310
Planned sale 13 Mar 2026
Value US$662,441.35 | Price 68.36 | Shares 9,690
Proposed sale 13 Mar 2026
Value US$9,517,200.00 | Price 67.98 | Shares 140,000
Planned sale 12 Mar 2026
Value US$21,045.00 | Price 70.15 | Shares 300
Planned sale 12 Mar 2026
Value US$402,928.91 | Price 69.29 | Shares 5,815
Planned sale 12 Mar 2026
Value US$950,686.51 | Price 68.47 | Shares 13,885
Planned sale 12 Mar 2026
Value US$21,045.00 | Price 70.15 | Shares 300
Planned sale 12 Mar 2026
Value US$371,750.29 | Price 69.32 | Shares 5,363
Planned sale 12 Mar 2026
Value US$981,809.23 | Price 68.48 | Shares 14,337
Planned sale 10 Mar 2026
Value US$624,312.00 | Price 72.00 | Shares 8,671
Proposed sale 10 Mar 2026
Value US$624,312.00 | Price 72.00 | Shares 8,671
Planned sale 4 Mar 2026
Value US$4,211,301.92 | Price 64.87 | Shares 64,921
Proposed sale 4 Mar 2026
Value US$4,211,300.16 | Price 64.87 | Shares 64,921
Planned sale 27 Feb 2026
Value US$739,496.33 | Price 67.84 | Shares 10,900
Planned sale 27 Feb 2026
Value US$978,284.51 | Price 67.08 | Shares 14,584
Proposed sale 27 Feb 2026
Value US$1,717,779.60 | Price 67.41 | Shares 25,484
Planned sale 26 Feb 2026
Value US$132,000.00 | Price 66.00 | Shares 2,000
Planned sale 19 Feb 2026
Value US$43,826.20 | Price 72.80 | Shares 602
Planned sale 19 Feb 2026
Value US$614,701.65 | Price 72.08 | Shares 8,528
Planned sale 19 Feb 2026
Value US$1,344,189.63 | Price 71.03 | Shares 18,923
Proposed sale 19 Feb 2026
Value US$2,073,958.29 | Price 73.93 | Shares 28,053
Planned sale 17 Feb 2026
Value US$37,898.10 | Price 74.31 | Shares 510
Planned sale 17 Feb 2026
Value US$15,076.00 | Price 75.38 | Shares 200
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-06-08 2026-06-05 PlS Planned sale
1.4
Kumar Neil

Chief Executive Officer

Executive Director
93,843 +18.3%
12.71
US$3,901,938 		93,843 +18.3% 12.71 US$3,901,938
2026-06-08 2026-06-05 PlS Planned sale
1.4
Kumar Neil

Chief Executive Officer

Executive Director
98,521 -29.6%
401.01
US$4,558,846 		98,521 -29.6% 401.01 US$4,558,846
2026-06-08 2026-06-05 PlS Planned sale
1.4
Kumar Neil

Chief Executive Officer

Executive Director
87,310 +14.0%
410.53
US$4,941,688 		87,310 +14.0% 410.53 US$4,941,688
2026-06-08 2026-06-05 PlS Planned sale
1.4
Kumar Neil

Chief Executive Officer

Executive Director
1,000 -0.8%
68.96
US$100,000 		1,000 -0.8% 68.96 US$100,000
2026-06-08 2026-06-05 PlS Planned sale
1.4
Kumar Neil

Chief Executive Officer

Executive Director
1,000 -1.6%
67.88
US$100,000 		1,000 -1.6% 67.88 US$100,000
2026-06-08 2026-06-05 PlS Planned sale
1.4
Kumar Neil

Chief Executive Officer

Executive Director
1,000 -1.3%
67.20
US$100,000 		1,000 -1.3% 67.20 US$100,000
2026-06-08 2026-06-04 PlS Planned sale
1.4
Kumar Neil

Chief Executive Officer

Executive Director
1,000 -0.0%
68.27
US$100,000 		1,000 -0.0% 68.27 US$100,000
2026-06-08 2026-06-04 PlS Planned sale
1.4
Kumar Neil

Chief Executive Officer

Executive Director
1,000 -0.4%
67.74
US$100,000 		1,000 -0.4% 67.74 US$100,000
2026-06-08 2026-06-04 PlS Planned sale
1.4
Kumar Neil

Chief Executive Officer

Executive Director
1,000 -0.0%
66.72
US$100,000 		1,000 -0.0% 66.72 US$100,000
2026-06-08 2026-06-04 PlS Planned sale
1.4
Kumar Neil

Chief Executive Officer

Executive Director
1,000 -0.1%
65.72
US$100,000 		1,000 -0.1% 65.72 US$100,000
2026-06-08 2026-06-04 PlS Planned sale
1.4
Kumar Neil

Chief Executive Officer

Executive Director
1,000 -0.1%
68.27
US$100,000 		1,000 -0.1% 68.27 US$100,000
2026-06-08 2026-06-04 PlS Planned sale
1.4
Kumar Neil

Chief Executive Officer

Executive Director
1,000 -2.9%
67.74
US$100,000 		1,000 -2.9% 67.74 US$100,000
2026-06-08 2026-06-04 PlS Planned sale
1.4
Kumar Neil

Chief Executive Officer

Executive Director
1,000 -0.3%
66.72
US$100,000 		1,000 -0.3% 66.72 US$100,000
2026-06-08 2026-06-04 PlS Planned sale
1.4
Kumar Neil

Chief Executive Officer

Executive Director
1,000 -0.4%
65.72
US$100,000 		1,000 -0.4% 65.72 US$100,000
2026-05-26 2026-05-21 PlS Planned sale
1.4
Kumar Neil

Chief Executive Officer

Executive Director
1,000 -0.3%
70.92
US$100,000 		1,000 -0.3% 70.92 US$100,000
2026-05-26 2026-05-21 PlS Planned sale
1.4
Kumar Neil

Chief Executive Officer

Executive Director
1,000 -4.4%
70.48
US$100,000 		1,000 -4.4% 70.48 US$100,000
2026-05-26 2026-05-21 PlS Planned sale
1.4
Kumar Neil

Chief Executive Officer

Executive Director
1,000 -1.9%
69.22
US$100,000 		1,000 -1.9% 69.22 US$100,000
2026-05-26 2026-05-21 PlS Planned sale
1.4
Kumar Neil

Chief Executive Officer

Executive Director
1,000 -2.5%
68.30
US$100,000 		1,000 -2.5% 68.30 US$100,000
2026-05-26 2026-05-21 PlS Planned sale
1.4
Kumar Neil

Chief Executive Officer

Executive Director
1,000 -0.8%
67.57
US$100,000 		1,000 -0.8% 67.57 US$100,000
2026-05-21 2026-05-21 PrS Proposed sale
1.4
NEIL KUMAR

Director; Officer

Executive Director
1,000
68.22
US$100,000 		1,000 68.22 US$100,000
2026-05-21 2026-05-21 PrS Proposed sale
1.4
NEIL KUMAR

Director; Officer

Executive Director
1,000
68.22
US$100,000 		1,000 68.22 US$100,000
2026-05-19 2026-05-18 PlS Planned sale
0.6
Trimarchi Thomas

President and CFO

Officer
3,195 -0.9%
65.95
US$210,712 		3,195 -0.9% 65.95 US$210,712
2026-05-19 2026-05-18 PlS Planned sale
0.6
Trimarchi Thomas

President and CFO

Officer
10,456 -2.8%
64.82
US$677,707 		10,456 -2.8% 64.82 US$677,707
2026-05-18 2026-05-18 PrS Proposed sale
0.6
THOMAS TRIMARCHI

Officer

Officer
13,651
65.08
US$888,419 		13,651 65.08 US$888,419
2026-05-19 2026-05-15 PlS Planned sale
2.6
Scott Randal W.
Non-Executive Director
200 -1.7%
69.12
US$13,824 		200 -1.7% 69.12 US$13,824
2026-05-19 2026-05-15 PlS Planned sale
2.6
Scott Randal W.
Non-Executive Director
1,512 -11.4%
68.23
US$103,164 		1,512 -11.4% 68.23 US$103,164
2026-05-19 2026-05-15 PlS Planned sale
2.6
Scott Randal W.
Non-Executive Director
2,088 -13.6%
67.53
US$141,003 		2,088 -13.6% 67.53 US$141,003
2026-05-19 2026-05-15 PlS Planned sale
2.6
Scott Randal W.
Non-Executive Director
6,200 -28.7%
66.69
US$413,464 		6,200 -28.7% 66.69 US$413,464
2026-05-11 2026-05-08 PlS Planned sale
1.4
Kumar Neil

Chief Executive Officer

Executive Director
950 -0.0%
68.35
US$64,930 		950 -0.0% 68.35 US$64,930
2026-05-11 2026-05-08 PlS Planned sale
1.4
Kumar Neil

Chief Executive Officer

Executive Director
5,076 -0.1%
67.35
US$341,846 		5,076 -0.1% 67.35 US$341,846
2026-05-11 2026-05-08 PlS Planned sale
1.4
Kumar Neil

Chief Executive Officer

Executive Director
13,974 -0.3%
66.65
US$931,374 		13,974 -0.3% 66.65 US$931,374
2026-05-11 2026-05-08 PlS Planned sale
1.4
Kumar Neil

Chief Executive Officer

Executive Director
950 -0.2%
68.35
US$64,930 		950 -0.2% 68.35 US$64,930
2026-05-11 2026-05-08 PlS Planned sale
1.4
Kumar Neil

Chief Executive Officer

Executive Director
5,077 -0.9%
67.35
US$341,913 		5,077 -0.9% 67.35 US$341,913
2026-05-11 2026-05-08 PlS Planned sale
1.4
Kumar Neil

Chief Executive Officer

Executive Director
13,973 -2.4%
66.65
US$931,307 		13,973 -2.4% 66.65 US$931,307
2026-05-11 2026-05-07 PlS Planned sale
1.4
Kumar Neil

Chief Executive Officer

Executive Director
449 -0.0%
69.09
US$31,022 		449 -0.0% 69.09 US$31,022
2026-05-11 2026-05-07 PlS Planned sale
1.4
Kumar Neil

Chief Executive Officer

Executive Director
8,334 -0.2%
68.38
US$569,858 		8,334 -0.2% 68.38 US$569,858
2026-05-11 2026-05-07 PlS Planned sale
1.4
Kumar Neil

Chief Executive Officer

Executive Director
11,217 -0.3%
67.49
US$757,090 		11,217 -0.3% 67.49 US$757,090
2026-05-11 2026-05-07 PlS Planned sale
1.4
Kumar Neil

Chief Executive Officer

Executive Director
450 -0.1%
69.09
US$31,091 		450 -0.1% 69.09 US$31,091
2026-05-11 2026-05-07 PlS Planned sale
1.4
Kumar Neil

Chief Executive Officer

Executive Director
8,333 -1.4%
68.38
US$569,790 		8,333 -1.4% 68.38 US$569,790
2026-05-11 2026-05-07 PlS Planned sale
1.4
Kumar Neil

Chief Executive Officer

Executive Director
11,217 -1.9%
67.50
US$757,091 		11,217 -1.9% 67.50 US$757,091
2026-05-04 2026-04-30 PlS Planned sale
1.2
Apuli Maricel

Chief Accounting Officer

Officer
2,000 -1.5%
71.58
US$143,160 		2,000 -1.5% 71.58 US$143,160
2026-04-13 2026-04-10 PlS Planned sale
1.4
Kumar Neil

Chief Executive Officer

Executive Director
20,000 -0.5%
74.60
US$1,492,076 		20,000 -0.5% 74.60 US$1,492,076
2026-04-13 2026-04-10 PlS Planned sale
1.4
Kumar Neil

Chief Executive Officer

Executive Director
20,000 -3.2%
74.60
US$1,492,096 		20,000 -3.2% 74.60 US$1,492,096
2026-04-13 2026-04-09 PlS Planned sale
1.4
Kumar Neil

Chief Executive Officer

Executive Director
7,800 -0.2%
75.53
US$589,124 		7,800 -0.2% 75.53 US$589,124
2026-04-13 2026-04-09 PlS Planned sale
1.4
Kumar Neil

Chief Executive Officer

Executive Director
5,128 -0.1%
74.57
US$382,379 		5,128 -0.1% 74.57 US$382,379
2026-04-13 2026-04-09 PlS Planned sale
1.4
Kumar Neil

Chief Executive Officer

Executive Director
7,072 -0.2%
73.64
US$520,801 		7,072 -0.2% 73.64 US$520,801
2026-04-13 2026-04-09 PlS Planned sale
1.4
Kumar Neil

Chief Executive Officer

Executive Director
7,500 -1.2%
75.55
US$566,661 		7,500 -1.2% 75.55 US$566,661
2026-04-13 2026-04-09 PlS Planned sale
1.4
Kumar Neil

Chief Executive Officer

Executive Director
5,300 -0.8%
74.60
US$395,403 		5,300 -0.8% 74.60 US$395,403
2026-04-13 2026-04-09 PlS Planned sale
1.4
Kumar Neil

Chief Executive Officer

Executive Director
7,200 -1.1%
73.64
US$530,240 		7,200 -1.1% 73.64 US$530,240
2026-04-09 2026-04-09 PrS Proposed sale
1.4
KUMAR HALDEA REVOCABLE TRUST U/A DTD 12/19/2018

Director; Officer

Executive Director
120,000
74.14
US$8,896,800 		120,000 74.14 US$8,896,800
2026-03-16 2026-03-13 PlS Planned sale
1.4
Kumar Neil

Chief Executive Officer

Executive Director
9,759 -0.2%
69.23
US$675,568 		9,759 -0.2% 69.23 US$675,568
2026-03-16 2026-03-13 PlS Planned sale
1.4
Kumar Neil

Chief Executive Officer

Executive Director
10,241 -0.2%
68.39
US$700,345 		10,241 -0.2% 68.39 US$700,345
2026-03-16 2026-03-13 PlS Planned sale
1.4
Kumar Neil

Chief Executive Officer

Executive Director
10,310 -1.6%
69.20
US$713,449 		10,310 -1.6% 69.20 US$713,449
2026-03-16 2026-03-13 PlS Planned sale
1.4
Kumar Neil

Chief Executive Officer

Executive Director
9,690 -1.5%
68.36
US$662,441 		9,690 -1.5% 68.36 US$662,441
2026-03-13 2026-03-13 PrS Proposed sale
1.4
KUMAR HALDEA FAMILY IRREVOCABLE TRUST

Director; Officer

Executive Director
140,000
67.98
US$9,517,200 		140,000 67.98 US$9,517,200
2026-03-16 2026-03-12 PlS Planned sale
1.4
Kumar Neil

Chief Executive Officer

Executive Director
300 -0.0%
70.15
US$21,045 		300 -0.0% 70.15 US$21,045
2026-03-16 2026-03-12 PlS Planned sale
1.4
Kumar Neil

Chief Executive Officer

Executive Director
5,815 -0.1%
69.29
US$402,929 		5,815 -0.1% 69.29 US$402,929
2026-03-16 2026-03-12 PlS Planned sale
1.4
Kumar Neil

Chief Executive Officer

Executive Director
13,885 -0.3%
68.47
US$950,687 		13,885 -0.3% 68.47 US$950,687
2026-03-16 2026-03-12 PlS Planned sale
1.4
Kumar Neil

Chief Executive Officer

Executive Director
300 -0.0%
70.15
US$21,045 		300 -0.0% 70.15 US$21,045
2026-03-16 2026-03-12 PlS Planned sale
1.4
Kumar Neil

Chief Executive Officer

Executive Director
5,363 -0.8%
69.32
US$371,750 		5,363 -0.8% 69.32 US$371,750
2026-03-16 2026-03-12 PlS Planned sale
1.4
Kumar Neil

Chief Executive Officer

Executive Director
14,337 -2.1%
68.48
US$981,809 		14,337 -2.1% 68.48 US$981,809
2026-03-12 2026-03-10 PlS Planned sale
2.8
Valantine Hannah
Non-Executive Director
8,671 -53.7%
72.00
US$624,312 		8,671 -53.7% 72.00 US$624,312
2026-03-10 2026-03-10 PrS Proposed sale
2.8
HANNAH A VALANTINE

Director

Non-Executive Director
8,671
72.00
US$624,312 		8,671 72.00 US$624,312
2026-03-06 2026-03-04 PlS Planned sale
2.3
Ellis Andrea
Non-Executive Director
64,921 -77.7%
64.87
US$4,211,302 		64,921 -77.7% 64.87 US$4,211,302
2026-03-04 2026-03-04 PrS Proposed sale
2.3
ANDREA ELLIS

Director

Non-Executive Director
64,921
64.87
US$4,211,300 		64,921 64.87 US$4,211,300
2026-03-03 2026-02-27 PlS Planned sale
2.8
Valantine Hannah
Non-Executive Director
10,900 -59.4%
67.84
US$739,496 		10,900 -59.4% 67.84 US$739,496
2026-03-03 2026-02-27 PlS Planned sale
2.8
Valantine Hannah
Non-Executive Director
14,584 -44.3%
67.08
US$978,285 		14,584 -44.3% 67.08 US$978,285
2026-02-27 2026-02-27 PrS Proposed sale
2.8
HANNAH A VALANTINE

Director

Non-Executive Director
25,484
67.41
US$1,717,780 		25,484 67.41 US$1,717,780
2026-02-27 2026-02-26 PlS Planned sale
1.2
Apuli Maricel

Chief Accounting Officer

Officer
2,000 -1.6%
66.00
US$132,000 		2,000 -1.6% 66.00 US$132,000
2026-02-23 2026-02-19 PlS Planned sale
1.4
Kumar Neil

Chief Executive Officer

Executive Director
602 -0.3%
72.80
US$43,826 		602 -0.3% 72.80 US$43,826
2026-02-23 2026-02-19 PlS Planned sale
1.4
Kumar Neil

Chief Executive Officer

Executive Director
8,528 -3.5%
72.08
US$614,702 		8,528 -3.5% 72.08 US$614,702
2026-02-23 2026-02-19 PlS Planned sale
1.4
Kumar Neil

Chief Executive Officer

Executive Director
18,923 -7.2%
71.03
US$1,344,190 		18,923 -7.2% 71.03 US$1,344,190
2026-02-19 2026-02-19 PrS Proposed sale
1.4
NEIL KUMAR

Director; Officer

Executive Director
28,053
73.93
US$2,073,958 		28,053 73.93 US$2,073,958
2026-02-18 2026-02-17 PlS Planned sale
1.2
Apuli Maricel

Chief Accounting Officer

Officer
510 -0.4%
74.31
US$37,898 		510 -0.4% 74.31 US$37,898
2026-02-18 2026-02-17 PlS Planned sale
0.6
Trimarchi Thomas

President and CFO

Officer
200 -0.1%
75.38
US$15,076 		200 -0.1% 75.38 US$15,076
Explore more

More insider trading research around BridgeBio Pharma Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Pharmaceuticals companies with insider activity
Insider trading in North America